Skip to search.
 FTSE 100 Up 0.04%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
6.30 Down 0.09(1.41%) 28 Apr 21:00
|After Hours: : 6.30 0.00 (0.00%) 21:28
Prev Close:6.39
Open:6.38
Bid:5.88 x 100
Ask:6.60 x 100
1y Target Est:18.40
Beta:2.71421
Next Earnings Date: 2-May-16SGMO Earnings announcement
Day's Range:6.26 - 6.64
52wk Range:4.63 - 13.57
Volume:532,212
Avg Vol (3m):946,141
Market Cap:443.52m
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMODown 1.41%443.52m
LLYDown 0.07%80.69b
AMGNDown 0.27%120.43b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.00
Quarterly EPS Est (Mar-16) :-0.24
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback